Simplex Trading
XENE icon

Simplex Trading’s Xenon Pharmaceuticals XENE Stock Holding History

Simplex Trading’s Portfolio XENE Stock Details XENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2,589
Closed -$104K – 9729
2024
Q2 		$100K Sell
2,589
-1,388
-35% -$55.5K ﹤0.01% 5379
2024
Q1 		$171K Sell
3,977
-24,410
-86% -$1.12M ﹤0.01% 5031
2023
Q4 		$1.31M Buy
28,387
+17,652
+164% +$624K ﹤0.01% 2764
2023
Q3 		$366K Buy
+10,735
New +$402K ﹤0.01% 3726
2022
Q4 		– Sell
-432
Closed -$15.7K – 10604
2022
Q3 		$15K Sell
432
-508
-54% -$18.3K ﹤0.01% 7853
2022
Q2 		$28K Buy
+940
New +$28.4K ﹤0.01% 7234
2021
Q4 		– Sell
-30,607
Closed -$915K – 11599
2021
Q3 		$566K Buy
30,607
+400
+1% +$6.95K ﹤0.01% 3892
2021
Q2 		$562K Buy
30,207
+10,065
+50% +$186K ﹤0.01% 3962
2021
Q1 		$360K Buy
+20,142
New +$341K ﹤0.01% 3882
2020
Q3 		– Sell
-126
Closed -$1K – 8650
2020
Q2 		$1K Buy
+126
New +$1.6K ﹤0.01% 7423

Other funds holding XENE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Simplex Trading's XENE Position: Q3 2024 in Review

Simplex Trading sold out of Xenon Pharmaceuticals (XENE) in Q3 2024, closing a stake of 2,589 shares — an estimated $104K sold.

Simplex Trading first reported a position in XENE in Q2 2020 and held it in 10 quarters. The position peaked at $1.31M in Q4 2023. 203 funds tracked by Wall St. Rank hold XENE as of Q3 2024.

  • Simplex Trading reported no remaining Xenon Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • Simplex Trading sold 2,589 Xenon Pharmaceuticals shares in Q3 2024, an estimated $104K.
  • Simplex Trading first reported a position in Xenon Pharmaceuticals in Q2 2020 and held it in 10 quarters.
  • Simplex Trading's Xenon Pharmaceuticals position peaked at $1.31M in Q4 2023.
  • 203 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q3 2024.

Based on Simplex Trading's 13F filing for Q3 2024, filed 8 Nov 2024.